Preparation of V3-V6-Fc- and Fab-and/or F(ab)2-modified purified material, control material, and characterization data

The Naval Medical Research Command (NMRC) intends to award a sole-source contract to Poly Solutions for specialized science and technology research and development services. The primary scope of work involves preparing V3-V6-Fc- and Fab-and/or F(ab)2-modified purified material and control material from NMRC crude Tc-bovine plasma. The contractor is required to generate characterization data for each material, specifically focusing on preparing V3-V6 modified material with a reduced or eliminated ability to cause antibody-dependent enhancement (ADE).

This requirement is classified under NAICS 541714 for Research and Development in Biotechnology (except Nanobiotechnology) and PSC AJ12 for General Science and Technology R&D Services; General Science and Technology; Applied Research. The project will be executed in Silver Spring, Maryland, under the guidelines of FAR Part 12 for Commercial Items. While the government proposes a non-competitive award to the vendor in Sioux Falls, South Dakota, it will consider capability statements from other interested parties submitted by the response deadline of June 12, 2026.

Naval Medical Research Command serves as the contracting office for solicitation 13013769616. All participating contractors must maintain active registration in the System for Award Management (SAM) and possess a Unique Entity Identification (UEI) number to be eligible for an award. Shamai Carter serves as the designated point of contact for this special notice, which includes no supplemental attachments.